Study of the effectiveness of the response and interferon combination therapy for ribavirin monotherapy for chronic hepatitis C
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000017560
- Lead Sponsor
- Hokkaido University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
We excluded: 1)HBs antibody positive 2))HIV antibody positive 3)decompensated liver chirrosis 4)severe herat failuer 5)severe kideny dysfunction 6)ineligible to interferon therapy
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effects of the combination therapy with interferon preceeded with ribavirin monotherapy.
- Secondary Outcome Measures
Name Time Method Adverse events of ribavirin monotherapy.